Emanuela Palmerini
Emanuela Palmerini
IRCCS Istitituto Ortopedico Rizzoli
Verified email at
Cited by
Cited by
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
G Prucher, M Assenza, B Binda, M Biondi, G Brachini, P Bruzzaniti, ...
Anaesthesia 76 (6), 748-758, 2021
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label …
A Gronchi, S Ferrari, V Quagliuolo, JM Broto, AL Pousa, G Grignani, ...
The Lancet Oncology 18 (6), 812-822, 2017
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ...
Annals of Oncology 32 (11), 1348-1365, 2021
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
G Grignani, E Palmerini, P Dileo, SD Asaftei, L D’ambrosio, Y Pignochino, ...
Annals of Oncology 23 (2), 508-516, 2012
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
G Grignani, E Palmerini, V Ferraresi, L D'Ambrosio, R Bertulli, SD Asaftei, ...
The lancet oncology 16 (1), 98-107, 2015
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
WD Tap, H Gelderblom, E Palmerini, J Desai, S Bauer, JY Blay, T Alcindor, ...
The Lancet 394 (10197), 478-487, 2019
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
S Ferrari, E Palmerini
Current opinion in oncology 19 (4), 341-346, 2007
Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study
JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, ...
Journal of Clinical Oncology 39 (1), 66, 2021
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial …
S Ferrari, P Ruggieri, G Cefalo, A Tamburini, R Capanna, F Fagioli, ...
Journal of clinical oncology 30 (17), 2112-2118, 2012
High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic …
G Bacci, M Rocca, MC Salone, A Balladelli, S Ferrari, E Palmerini, C Forni, ...
Journal of surgical oncology 98 (6), 415-420, 2008
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, E Palmerini, S Piperno-Neumann, C Perrin, ...
Annals of oncology 24 (11), 2916-2922, 2013
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ...
Annals of oncology 33 (1), 20-33, 2022
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ...
The Lancet Oncology 22 (11), 1507-1517, 2021
Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution
E Palmerini, EL Staals, M Alberghini, L Zanella, C Ferrari, MS Benassi, ...
Cancer 115 (13), 2988-2998, 2009
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study
S Chawla, JY Blay, P Rutkowski, A Le Cesne, P Reichardt, H Gelderblom, ...
The Lancet Oncology 20 (12), 1719-1729, 2019
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
A Gronchi, E Palmerini, V Quagliuolo, J Martin Broto, A Lopez Pousa, ...
Journal of Clinical Oncology 38 (19), 2178-2186, 2020
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
SJ Strauss, AM Frezza, N Abecassis, J Bajpai, S Bauer, R Biagini, ...
Annals of Oncology 32 (12), 1520-1536, 2021
Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution
M Cesari, F Bertoni, P Bacchini, M Mercuri, E Palmerini, S Ferrari
Tumori Journal 93 (5), 423-427, 2007
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): for how long?
E Palmerini, NS Chawla, S Ferrari, M Sudan, P Picci, E Marchesi, ...
European Journal of Cancer 76, 118-124, 2017
Phase II study on lapatinib in advanced EGFR-positive chordoma
S Stacchiotti, E Tamborini, SL Vullo, F Bozzi, A Messina, C Morosi, ...
Annals of oncology 24 (7), 1931-1936, 2013
The system can't perform the operation now. Try again later.
Articles 1–20